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Background: Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome 
is characterized by cutaneous drug eruption, eosinophilia, and systemic symptoms. The 
syndrome is difficult to diagnose due to its clinical heterogeneity and long latency period 
(2–6 weeks).
Case report: This paper describes a 73-year-old man who presented with a rash that started 
1 week prior to his presentation. The rash was associated with fever, dyspnea, and cough. 
He was admitted for pneumonia and started on intravenous antibiotics. After 3 days, he 
became confused and developed multiorgan dysfunction. Work-up for possible hematologic 
disorders, autoimmune diseases, and pneumonia was negative. One month prior to the onset 
of the rash, allopurinol had been prescribed for asymptomatic hyperuricemia. The allopurinol 
was stopped and corticosteroids were started; 2 days later, the patient became afebrile and the 
dyspnea resolved. He was diagnosed with DRESS syndrome, which is associated with high   
mortality.
Conclusion: The recent introduction of a drug followed by a rash, multiorgan dysfunction, and 
eosinophilia should raise the suspicion of DRESS syndrome. Early cessation of the introduced 
drug is key to survival. Clinicians should be aware of this potential adverse reaction when 
prescribing any new drug, including allopurinol.
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Introduction
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome is character-
ized by cutaneous drug eruption, eosinophilia, and systemic symptoms (lymphade-
nopathy, hepatitis, interstitial nephritis, interstitial pneumonitis, and/or carditis).1 This 
paper describes a patient with DRESS syndrome caused by allopurinol, the clinical 
presentation of which mimicked community-acquired pneumonia.
Case report
A 73-year-old man presented with a 1-week history of rash, which first appeared on 
the trunk and then spread to the face and upper extremities (Figures 1 and 2). Two days 
later, the rash symmetrically involved the lower extremities (Figure 3) and fever and 
chills began. He complained of shortness of breath with mild, nonproductive cough. 
He was anxious and dyspneic upon presentation. He denied any weight loss, night 
sweats, headache, abdominal pain, chest pain, or urinary symptoms. He had a history 
of hypertension, coronary artery syndrome, dyslipidemia, and had received coronary International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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artery bypass surgery 3 years before. The patient was a heavy 
smoker (50 pack-years), drank alcohol socially, and had   
no history of illicit drug use. His medications included 
aspirin 75 mg per day, atenolol 50 mg per day, simvastatin 
40 mg per day, and bezafibrate (a fibric-acid derivative 
  available in Europe) 200 mg three times per day, which 
had been started 5 years prior. Allopurinol for hype-
ruricemia at 300 mg per day was started 1 month prior to   
presentation.
The patient was born in the USA and had immigrated 
to England during childhood. On presentation, he was 
in the USA visiting family. He was married and in a 
monogamous relationship with his wife. He was retired 
and did not own any pets nor was he aware of any tick or 
flea bites. There was no history of asthma or rash, nor any 
known allergies.
On examination, his heart rate was 90 beats/minute, 
respiratory rate 20 breaths/minute, blood pressure 
150/70 mmHg, temperature 38.5°C, SpO2 90% on room 
air and 96% on 2 L/minute nasal cannula oxygen. He had 
periorbital edema; a scaling, confluent erythematous rash 
all over his face; scleral erythema; and crusting of the lips. 
A macular rash covered the trunk and upper extremities, 
slightly involved the palms, spared the scalp, and became 
more confluent and purpuric over the lower extremities 
(sparing the soles). There were bilateral wheezing and crack-
les in both lower lung fields. Meningeal signs were absent. 
The remainder of the examination was normal. Laboratory 
data included white blood cell count of 8500/*109/L with 
68% neutrophils and 12% eosinophils, alanine transaminase 
210 U/L, aspartate aminotransferase 165 U/L, blood urea 
nitrogen 19 mg/dL, and creatinine 1.7 mg/dL. Chest X-ray 
showed bilateral interstitial infiltrates with left lower lobe 
atelectasis (Figure 4). Urine analysis was normal.
The patient was admitted to a regular ward for 
pneumonia treatment and started on ceftriaxone 2 g intra-
venous once daily and levofloxacine 750 mg intravenous 
once daily. On the second day, sputum Gram stain showed 
squamous   epithelial cells and a fungal wet preparation 
showed no organisms. The patient continued to be febrile 
for the next 2 days, and became confused with increased 
shortness of breath and more wheezing and crackles on 
chest exam. Cultures of the blood and urine were sterile. 
A urine test for Legionella antigen and a serum test for 
antibodies to Legionella pneumophilia were negative. 
Salmonella   antigen, Brucella-blocking antibodies, viral 
hepatitis panel (hepatitis A, hepatitis B, hepatitis C), 
and Epstein–Barr virus immunoglobulin levels were all 
normal; Weil–Felix test for rickettsia was negative. Stool 
for parasites was negative. Immunoglobulin E level was 
also normal.
The allopurinol was stopped and he was started on meth-
ylprednisolone 60 mg intravenous every 8 hours. Two days 
later, the patient became afebrile, the dyspnea resolved, the 
rash improved significantly, and there was complete resolution 
Figure 1 Scaling of the diffuse confluent erythema all over the patient’s face. 
Figure 2 Macular lesions all over the trunk. Figure 3 spreading of the rash symmetrically to the lower extremities, purpuric type.International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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of the kidney and hepatic injury. The eosinophil count also 
returned to a normal value after 5 days (Table 1).
Discussion
One outstanding feature of this case is eosinophilia. 
Eosinophilia occurs in hematologic, allergic,   autoimmune, 
and infectious diseases.2 The eosinophilia in this case 
was associated with a cutaneous rash, hepatitis, kid-
ney dysfunction, mental status changes, and interstitial 
  pneumonitis. In this clinical context (eosinophilia with 
multiorgan involvement), the differential diagnoses 
would be: Churg–Strauss syndrome (CSS), idiopathic 
hypereosinophilic syndrome, eosinophilic leukemia, or 
drug-induced eosinophilia. The actual presentation of an 
“asthma-like” exacerbation with eosinphilia is consistent 
with CSS, but does not fulfill the criteria for this diagnosis. 
Furthermore, the patient had no   history of asthma or sinus 
abnormality and skin lesions in CSS usually appear as 
subcutaneous nodules on the extensor surfaces.3   Migratory 
or transient pulmonary opacities detected radiographi-
cally, along with evidence of a peripheral   neuropathy, are 
required for the diagnosis of CSS. The absence of immature   
eosinophils in the peripheral blood smear makes the diag-
nosis of eosinophilic leukemia unlikely. Hypereosinophilic 
syndrome is a diagnosis of exclusion when no apparent cause 
of eosinophilia is   diagnosed, which was not the case in this 
patient.4 The recent introduction of allopurinol raised the 
suspicion of DRESS syndrome.
DRESS syndrome, previously known as drug-induced 
hypersensitivity, is characterized by fever, cutaneous eruption, 
and involvement of several internal organs – most commonly 
the liver and, to a lesser extent, the kidneys, lungs, and brain. 
The cutaneous reaction usually begins 2–6 weeks after the 
drug is started and is due to a delayed-type hypersensitivity 
reaction.5 The rash presents as a widespread erythematous 
eruption on the face, upper trunk, and upper extremities and 
is accompanied by fever, facial and periorbital edema, and/
or exfoliative dermatitis. Eruption may become purpuric on 
the legs and rarely involves the palms and soles, and virtually 
never involves the scalp.5 Scaling and/or desquamation may 
occur with healing. The most common drug class implicated 
is anticonvulsants, including phenytoin, lamotrigine, and 
carbamazepine; other drugs known to cause this syndrome 
include allopurinol, minocycline, dapsone, and sulfon-
amides.6 Although the pathophysiology is still unknown, 
different factors have been postulated in DRESS syndrome’s 
etiology – mainly immunologic and genetic factors and 
metabolite accumulation. Drugs with reactive metabolites 
can modify cellular proteins and trigger an autoimmune 
response against the skin or liver cells.7 The metabolism 
of allopurinol and consequent accumulation of oxypurinol, 
especially in patients with renal insufficiency or those on 
thiazides diuretics, may predispose the patient to an immuno-
logic reaction.8 A recent study in the Han Chinese population 
found that HLA-B*5801 is a genetic marker for the DRESS 
syndrome caused by allopurinol.9 Also, allopurinol’s inhibition 
of the enzyme purine nucleoside phosphorylase, which results 
in defective T-cell-mediated immunity, is due to a genetic 
predisposition. One study suggests a role for the human 
herpes virus 6 in the pathogenesis of DRESS syndrome.7 
Early cessation of the drug implicated in the development of 
DRESS   syndrome will result in a better outcome. Corticos-
teroids have been used for treatment of DRESS syndrome, 
Figure 4 Chest X-ray: left lower lobe atelectasis with bilateral interstitial infiltrates.
Table 1 Patient’s laboratory data
Date WBCs/PMNs  
(*109/L)
Eosinophils BUN/Cr  
(mg/dL)
ALT/AST  
(U/L)
Alk ph/GGT  
(U/L)
INR
7/31/09 8500/68% 12% 19/1.7 210/165 80/133
8/2/09 21,300/62% 16% 59/2.4 476/309 85/141 1.44
8/8/09 15,000/91% 1% 34/1.22 168/75 227/503 1.38
8/13/09 12,500/75% 0% 31/1.12 70/76 114/514 1.28
Abbreviations: ALT, alanine transaminase; AsT, asparte aminotransferase; BUN, blood urea nitrogen; Alk ph, alkaline phosphatase; GGT, gamma-glutamyl transferase; INr, 
international normalized ratio; Cr, creatinine; WBCs, white blood cells; PMNs, polymorphonuclear cells.International Journal of General Medicine
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but their role remains controversial. Unfortunately, a review 
of the literature found that 80% of patients with allopurinol-
induced DRESS syndrome were treated for asymptomatic 
hyperuricemia.10 Currently, the only indications for allopurinol 
include symptomatic hyperuricemia, such as nephrolithiasis 
and gout, and prophylaxis for urate nephropathy with chemo-
therapy in neoplastic diseases.
Conclusion
A drug allergy should always be suspected in a patient 
presenting with a whole-body rash and eosinophilia, espe-
cially if a new medication was recently started. Allopurinol-
induced DRESS syndrome is associated with significant 
mortality (10%). The use of allopurinol for accepted indica-
tions and dose adjustment for renal dysfunction are the only 
ways to decrease the incidence of the potentially fatal toxic 
effects of this medication.
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